Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2016, Vol. 43 Issue (4): 555-559    DOI: 10.12891/ceog3037.2016
Original Research Previous articles | Next articles
Effect of a low glycemic diet in patients with polycystic ovary syndrome and anovulation - a randomized controlled trial
L. H. Sordia-Hernández1, *(), P. Ancer Rodríguez2, D. Saldivar Rodriguez1, S. Trejo Guzmán2, E. S. Servín Zenteno1, G. Guerrero González1, R. Ibarra Patiño1
1Centro Universitario de Medicina Reproductiva, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey
2Departamento de Nutrición, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey (Mexico)
Download:  PDF(155KB)  ( 18 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To determine whether a low glycemic index diet is better than a normal glycemic index diet in producing ovulatory cycles in women with polycystic ovary syndrome (PCOS) and anovulation. Materials and Methods: A randomized controlled clinical trial involving 37 women with PCOS and anovulation. The authors randomly assigned low glycemic index diets (n = 19) and normal glycemic index (n = 18) diets, and analyzed the number of ovulatory cycles for three months. Results: In patients who consumed a low glycemic index diet, 24.6% (14/57) of the cycles were ovulatory. In those who consumed a normal glycemic index diet, only 7.4% (4/54) of the cycles were ovulatory (p = 0.014). Conclusions: The difference observed in the number of ovulatory cycles could be related to a decrease in the serum levels of circulating androgens, secondary to an improvement in insulin resistance.
Key words:  Glycemic index      Ovulatory cycles      Polycystic ovary syndrome      Metabolic syndrome.     
Published:  10 August 2016     
*Corresponding Author(s):  L. H. SORDIA-HERNÁNDEZ     E-mail:  luissordia@telmexmail.com

Cite this article: 

L. H. Sordia-Hernández, P. Ancer Rodríguez, D. Saldivar Rodriguez, S. Trejo Guzmán, E. S. Servín Zenteno, G. Guerrero González, R. Ibarra Patiño. Effect of a low glycemic diet in patients with polycystic ovary syndrome and anovulation - a randomized controlled trial. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(4): 555-559.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3037.2016     OR     https://ceog.imrpress.com/EN/Y2016/V43/I4/555

[1] Chang Liu, Minchen Dai, Lei Zhao, Fangfang Wang. The effects of Chinese herbal medicine on the pregnancy outcomes of infertile women with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1032-1043.
[2] Zhenzhen Lu, Ying Gao. Searching for biomarkers in the progression from polycystic ovary syndrome to endometrial carcinoma[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1117-1125.
[3] Gonca Özten Dere, Esra Uyanik, Fatih Aktoz, Pınar Çalış, Sezcan Mümüşoğlu, Hakan Yarali, Gürkan Bozdağ. The effect of laparoscopic ovarian drilling on timing of menopause in patients with polycystic ovary syndrome: 29 years of follow-up data[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 590-593.
[4] Hye Won Lee, Lin Ang, Myeong Soo Lee, Kyoung Sun Park, Jin-Moo Lee, Chang-Hoon Lee, Dong Chul Kim, Jeong-Eun Yoo, Seung-Jeong Yang, Tae-Young Choi. Prescription patterns of herbal medicine for polycystic ovarian syndrome in major Korean medicine hospitals: a multicenter retrospective study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 649-653.
[5] J. Dun, X. Wang, J. Yang, J. Xu. Clinical practice guidelines on polycystic ovary syndrome: a systematic review and comparative meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 465-471.
[6] Xiao-Tao Huang, Shao-Rong Liang, Lu Wang. Acupuncture combined with Chinese and western medicine in the treatment of polycystic ovary syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 396-400.
[7] A. M. Maysara, A. T. Nassar, H. K. Jubran. The effect of correction of serum level of vitamin D on hyperandrogenism in women with polycystic ovary syndrome and hypovitaminosis D[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 272-276.
[8] H.M.G. Youssef, E.S. Marei, L.A. Rashed. Long non-coding RNA steroid receptor activator in polycystic ovary syndrome: possible association with metabolic syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 757-762.
[9] M.H. Vieira de Melo, M.T. Albuquerque Barbosa Cabral Micussi, R. Dias de Medeiros, R. Ney Cobucci, T.M. de Oliveira Maranhão, A.K. Gonçalves. Pelvic floor muscle thickness in women with polycystic ovary syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 813-816.
[10] Hui-lan Wang, Xia Xu, Zhi-qun Zheng. The expression of Nuclear Factor-κB in a rat model of polycystic ovary syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 276-279.
[11] P. Marques, F. Ferreira, A. P. Soares, J. Nunes, S. Sousa, A. Aguiar, C. Calhaz-Jorge. Clinico-biochemical characteristics of 229 Portuguese infertile women with polycystic ovary syndrome: clinical relevance and relationship with fertility treatment results[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(6): 812-817.
[12] S. Hacivelioglu, A. Uysal, A.N. Cakir Gungor, M. Gencer, D.U. Cakir, E. Cosar. The effect of maternal polycystic ovary morphology on first-trimester maternal serum biochemical markers of aneuploidy and fetal nuchal translucency thickness[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(1): 32-35.
[13] W. Li, Y. Chen, L. Xu. Association of sympathetic nervous system activity with polycystic ovarian syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(5): 499-506.
[14] L. Hu, H. Shen, Q.F. Wu, L. Tian, M.H. Hu. Treatment of polycystic ovarian syndrome with insulin resistance by insulin-sensitizer[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(3): 288-292.
[15] Yueqiao Zhen, Peng Yang, Ruihong Dong, Yumin Wu, Yanhong Sang, Xiaoxiao Du, Yan Wang, Qiuyan Song, Ling Yu, Xiaojuan Rao. Effect of HbA1C detection on the diagnostic screening for glucose metabolic disorders in polycystic ovary syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(1): 58-61.
No Suggested Reading articles found!